Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages

Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages

Abstract Background We systematically reviewed the comparative effectiveness of injectable beta-interferons (IFN-β) and glatiramer acetate (GA) on annualised relapse rate (ARR), progression and discontinuation due to adverse events (AEs) in RRMS, using evidence from within the drugs’ recommended dos...

Full description

Bibliographic Details
Main Authors: G. J. Melendez-Torres, Xavier Armoiry, Rachel Court, Jacoby Patterson, Alan Kan, Peter Auguste, Jason Madan, Carl Counsell, Olga Ciccarelli, Aileen Clarke
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Clinically isolated syndrome
Beta-interferon
Glatiramer acetate
Systematic review
Economic evaluation
Online Access:http://link.springer.com/article/10.1186/s12883-018-1162-9

Internet

http://link.springer.com/article/10.1186/s12883-018-1162-9

Similar Items